Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Manly, J. Olson (1999)
Overview of QTL mapping software and introduction to Map Manager QTMammalian Genome, 10
I. Bièche, R. Lidereau (1995)
Genetic alterations in breast cancerGenes, 14
D. Liaw, D. Marsh, Jing Li, P. Dahia, Steven Wang, Zimu Zheng, S. Bose, K. Call, H. Tsou, Monica Peacoke, C. Eng, R. Parsons (1997)
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndromeNature Genetics, 16
E. Lander, L. Kruglyak (1995)
Genetic dissection of complex traits: guidelines for interpreting and reporting linkage resultsNature Genetics, 11
J. Struewing, P. Hartge, S. Wacholder, Sonya Baker, M. Berlin, M. McAdams, Michelle Timmerman, L. Brody, M. Tucker (1997)
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.The New England journal of medicine, 336 20
D. Singh, K. Deome, Howard Bern (1970)
Strain differences in response of the mouse mammary gland to hormones in vitro.Journal of the National Cancer Institute, 45 4
R. Wooster, G. Bignell, J. Lancaster, S. Swift, S. Seal, J. Mangion, N. Collins, S. Gregory, C. Gumbs, G. Micklem, R. Barfoot, R. Hamoudi, Sandeep Patel, Catherine Rices, P. Biggs, Yasmin Hashim, Amanda Smith, F. Connor, A. Arason, J. Gudmundsson, David Flcenec, D. Kelsell, D. Ford, P. Tonin, P. Tonin, D. Bishop, N. Spurr, B. Ponder, R. Eeles, J. Peto, P. Devilee, C. Cornelisse, H. Lynch, S. Narod, S. Narod, G. Lenoir, V. Egilsson, Rosa Barkadottir, D. Easton, D. Bentley, P. Futreal, A. Ashworth, M. Stratton (1995)
Identification of the breast cancer susceptibility gene BRCA2Nature, 378
S. Narod, D. Goldgar, L. Cannon-Albright, B. Weber, R. Moslehi, E. Ives, G. Lenoir, H. Lynch (1995)
Risk modifiers in carriers of brca1 mutationsInternational Journal of Cancer, 64
C. Guy, R. Cardiff, W. Muller (1992)
Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic diseaseMolecular and Cellular Biology, 12
L. Friedman, C. Szabo, E. Ostermeyer, P. Dowd, L. Butler, Tari Park, Ming Lee, E. Goode, S. Rowell, M. King (1995)
Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families.American journal of human genetics, 57 6
S. Narod, J. Feunteun, H. Lynch, P. Watson, T. Conway, J. Lynch, G. Lenoir (1991)
Familial breast-ovarian cancer locus on chromosome 17q12-q23The Lancet, 338
Vessey Mp (1997)
Effect of endogenous and exogenous hormones on breast cancer: epidemiology.Verhandlungen der Deutschen Gesellschaft fur Pathologie, 81
W. Frankel (1995)
Taking stock of complex trait genetics in mice.Trends in genetics : TIG, 11 12
Y. Miki, J. Swensen, D. Shattuck-Eidens, P. Futreal, K. Harshman, S. Tavtigian, Qingyun Liu, C. Cochran, L. Bennett, W. Ding, R. Bell, J. Rosenthal, C. Hussey, Thanh Tran, M. Mcclure, C. Frye, T. Hattier, R. Phelps, A. Haugen-Strano, H. Katcher, Kazuko Yakumo, Z. Gholami, Daniel Shaffer, S. Stone, Steven Bayer, Christian Wray, R. Bogden, P. Dayananth, J. Ward, P. Tonin, S. Narod, Pamela Bristow, F. Norris, L. Helvering, P. Morrison, P. Rosteck, Mei Lai, J. Barrett, C. Lewis, S. Neuhausen, L. Cannon-Albright, D. Goldgar, R. Wiseman, A. Kamb, M. Skolnick (1994)
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.Science, 266 5182
V. Kristensen, T. Andersen, A. Lindblom, Bjoørn Erikstein, P. Magnus, A. Børresen-Dale (1998)
A rare CYP19 (aromatase) variant may increase the risk of breast cancer.Pharmacogenetics, 8 1
C. Szabo, M. King (1997)
Population genetics of BRCA1 and BRCA2.American journal of human genetics, 60 5
K. Helzlsouer, R. Couzi (1995)
Hormones and breast cancerCancer, 76
T. Krontiris, B. Devlin, D. Karp, N. Robert, N. Risch (1993)
An association between the risk of cancer and mutations in the HRAS1 minisatellite locus.The New England journal of medicine, 329 8
Traci Lifsted, T. Voyer, Max Williams, W. Muller, A. Klein-Szanto, K. Buetow, K. Hunter (1998)
Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progressionInternational Journal of Cancer, 77
P. Athma, Rebecca Rappaport, M. Swift (1996)
Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer.Cancer genetics and cytogenetics, 92 2
G. Ursin, B. Henderson, R. Haile, M. Pike, Nianmin Zhou, A. Diep, L. Bernstein (1997)
Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?Cancer research, 57 17
D. Easton, D. Bishop, D. Ford, G. Crockford (1993)
Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.American journal of human genetics, 52 4
Y. Sekido, M. Ahmadian, I. Wistuba, F. Latif, S. Bader, M. Wei, F. Duh, A. Gazdar, M. Lerman, J. Minna (1998)
Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor geneOncogene, 16
R. Anbazhagan, H. Fujii, E. Gabrielson (1998)
Allelic loss of chromosomal arm 8p in breast cancer progression.The American journal of pathology, 152 3
A. Langston, K. Malone, J. Thompson, J. Daling, Elaine Ostrander (1996)
BRCA1 mutations in a population-based sample of young women with breast cancer.The New England journal of medicine, 334 3
William Dietrich, Hillary Katz, Stephen Lincoln, Hee-Sup Shin, J. Friedman, N. Dracopoli, Eric Lander (1992)
A genetic map of the mouse suitable for typing intraspecific crosses.Genetics, 131 2
Hulka Bs (1997)
Epidemiologic analysis of breast and gynecologic cancers.Progress in Clinical and Biological Research, 396
B. Newman, M. Austin, Ming Lee, Mary King (1988)
Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families.Proceedings of the National Academy of Sciences of the United States of America, 85 9
D. Goldgar, Patty Fields, Cathryn Lewis, T. Tran, L. Cannon-Albright, John Ward, J. Swensen, M. Skolnick (1994)
A large kindred with 17q-linked breast and ovarian cancer: genetic, phenotypic, and genealogical analysis.Journal of the National Cancer Institute, 86 3
C. Phelan, T. Rebbeck, B. Weber, P. Devilee, M. Ruttledge, H. Lynch, G. Lenoir, M. Stratton, D. Easton, B. Ponder, L. Cannon-Albright, C. Larsson, D. Goldgar, S. Narod (1996)
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locusNature Genetics, 12
R. Doerge, G. Churchill (1996)
Permutation tests for multiple loci affecting a quantitative character.Genetics, 142 1
D. Easton, L. Steele, P. Fields, W. Ormiston, D. Averill, P. Daly, R. McManus, S. Neuhausen, D. Ford, R. Wooster, L. Cannon-Albright, Michael Stratton, D. Goldgar (1997)
Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.American journal of human genetics, 61 1
S. Khan, M. Rogers, K. Khurana, M. Meguid, P. Numann (1998)
Estrogen receptor expression in benign breast epithelium and breast cancer risk.Journal of the National Cancer Institute, 90 1
D. Ford, D. Easton, J. Peto (1995)
Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence.American journal of human genetics, 57 6
N. Andrieu, S. Duffy, Teresa Rohan, M. Lê, É. Luporsi, M. Gerber, R. Renaud, D. Zaridze, Y. Lifanova, N. Day (1995)
Familial risk, abortion and their interactive effect on the risk of breast cancer--a combined analysis of six case-control studies.British Journal of Cancer, 72
Previous studies from our laboratory demonstrated that the latency, tumor growth, and metastatic progression of polyoma middle T-induced mammary tumor in an FVB/NJ inbred mouse background could be significantly altered by the introduction of different genetic backgrounds. In this study we extend these findings by mapping a number of interacting quantitative trait loci responsible for the changes in phenotype. Introduction of the I/LnJ inbred genetic background into the FVB/NJ-PyMT animal significantly accelerated the appearance of the primary tumor (35 vs. 57 days postnatal, p < 10−7). A backcross mapping panel was established, and loci responsible for the tumor acceleration were detected on Chrs 15 and 9. Examination of the genotype/phenotype correlation revealed that the FVB/NJ but not the I/LnJ allele of the Chr 15 locus was associated with tumor acceleration and was conditional on the presence of I/LnJ allele on Chr 9. These loci, designated Apmt1 and Apmt2, map to homologous regions associated with LOH in human breast cancer. These results suggest that allelic variants of genes in these regions may contribute to age of onset in human breast cancer.
Mammalian Genome – Springer Journals
Published: Feb 27, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.